Efficacy, pharmacokinetic, and safety assessment of adalimumab, a fully human anti-tumor necrosis factor-alpha monoclonal antibody, in adults with rheumatoid arthritis receiving concomitant methotrexate: A pilot study
2003 ◽
Vol 25
(6)
◽
pp. 1700-1721
◽
2005 ◽
Vol 77
(2)
◽
pp. P43-P43
◽
1996 ◽
pp. 143-152
2017 ◽
Vol 63
(4)
◽
pp. 215
◽
2016 ◽
Vol 36
(5)
◽
pp. 625-633
◽